This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Nutraceutical Increases Credit Line

PARK CITY, Utah, Dec. 21, 2010 /PRNewswire-FirstCall/ -- Nutraceutical International Corporation (Nasdaq: NUTR) has amended and restated its original January 2002 revolving credit facility agreement.  Rabobank International will continue as our lead bank under the facility.  Wells Fargo will also remain as a lender and is currently our primary US commercial banking partner.  This amended and restated credit facility extends the term of the loan to December 2015, increases the ongoing commitment from our banks to $90 million for the next five years and provides an additional accordion feature to increase the commitment up to $120 million, subject to certain conditions.  Outstanding borrowings under the facility are currently $33 million.

Bill Gay, chairman and chief executive officer, commented, "We are pleased to continue our long relationship with Rabobank and Wells Fargo and to renew our revolving credit facility with them.  We have a well established relationship with these banks and they are knowledgeable about our business and our industry.  This credit facility provides us with flexible financing to pursue our long-term business strategies."  

ABOUT NUTRACEUTICAL

We are an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores.  Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers.  Our core business strategy is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements.  We believe that the consolidation and integration of these acquired businesses provides ongoing financial synergies through increased scale and market penetration, as well as strengthened customer relationships.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,110.14 +72.17 0.40%
S&P 500 2,114.90 +5.98 0.28%
NASDAQ 5,055.4220 -4.8240 -0.10%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs